Once it's ready, please submit your draft for review by our team of Community Moderators. Thank you!
You have been invited to co-author this question.
When it is ready, the author will submit it for review by Community Moderators. Thanks for helping!
Pending
This question now needs to be reviewed by Community Moderators.
We have high standards for question quality. We also favor questions on our core topic areas or that we otherwise judge valuable. We may not publish questions that are not a good fit.
If your question has not received attention within a week, or is otherwise pressing, you may request review by tagging @moderators in a comment.
You have been invited to co-author this question.
It now needs to be approved by Community Moderators. Thanks for helping!
There is a lot of excitement about the use of mRNA technology to develop therapeutic cancer vaccines. The German firm BioNTech have four such vaccines undergoing Phase II trials at the moment.
Outside of the crisis-mode of pandemic vaccines, it usually takes years to get from Phase II to approval.